Bhavjinder Kaur Dhillon

Bhavjinder Kaur Dhillon

Auto-generated profile, based on publicly available information

Bhavjinder Kaur Dhillon

Department of Microbiology & Immunology, University of British Columbia, 1365-2350 Health Sciences Mall, Vancouver, BC, Canada

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 December 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
CBCorrie R. Belanger
Corrie R. Belanger
ALAmy Huei-Yi Lee
Amy Huei-Yi Lee
DPDaniel Pletzer
Daniel Pletzer
BDBhavjinder Kaur Dhillon
Bhavjinder Kaur Dhillon
RFReza Falsafi
Reza Falsafi
RHRobert E. W. Hancock
Robert E. W. Hancock
Significance: The host environment in which infection occurs plays a crucial role in the interaction between Pseudomonas aeruginosa and antibiotic treatments. To make up for the lack of new antibiotics, alternative approaches, such as combination therapy and discovery of novel activity of known antibiotics in the host environment, are vital for treatment of pathogens such as P. aeruginosa. This research demonstrates how in vitro conditions that closely mimic human infection more accurately reflect the antimicrobial activity of antibiotics. We have shown that azithromycin (AZM) has increased activity and synergy with synthetic peptides in physiologically relevant in vitro conditions and in vivo. Furthermore, this research also provides potential alternative mechanisms for the activity of AZM against P. aeruginosa .

8 November 2022 in Scientific Data
Verified
Journal Article
Open access
PDF file
KSKenneth C. Smith
Kenneth C. Smith
DCDaniel G. Chawla
Daniel G. Chawla
BDBhavjinder K. Dhillon
Bhavjinder K. Dhillon
ZJZhou Ji
Zhou Ji
RVRandi Vita
Randi Vita
SKSteven H. Kleinstein
Steven H. Kleinstein
Recent advances in high-throughput experiments and systems biology approaches have resulted in hundreds of publications identifying “immune signatures”. Unfortunately, these are often described within text, figures, or tables in a format not amenable to computational processing, thus severely hampering our ability to fully exploit this information. Here we present a data model to represent immune signatures, along with the Human Immunology Project Consortium (HIPC) Dashboard (www.hipc-dashboard.org), a web-enabled application to facilitate signature access and querying. The data model captures the biological response components (e.g., genes, proteins, cell types or metabolites) and metadata describing the context under which the signature was identified using standardized terms from established resources (e.g., HGNC, Protein Ontology, Cell Ontology). We have manually curated a collection of >600 immune signatures from >60 published studies profiling human vaccination responses for the current release. The system will aid in building a broader understanding of the human immune response to stimuli by enabling researchers to easily access and interrogate published immune signatures.

17 September 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
DMDavid Martino
David Martino
NKNina Kresoje
Nina Kresoje
NANelly Amenyogbe
Nelly Amenyogbe
RBRym Ben-Othman
Rym Ben-Othman
BCBing Cai
Bing Cai
TKTobias R. Kollmann
Tobias R. Kollmann
Understanding of newborn immune ontogeny in the first week of life will enable age-appropriate strategies for safeguarding vulnerable newborns against infectious diseases. Here we conducted an observational study exploring the immunological profile of infants longitudinally throughout their first week of life. Our Expanded Program on Immunization - Human Immunology Project Consortium (EPIC-HIPC) studies the epigenetic regulation of systemic immunity using small volumes of peripheral blood samples collected from West African neonates on days of life (DOL) 0, 1, 3, and 7. Genome-wide DNA methylation and single nucleotide polymorphism markers are examined alongside matched transcriptomic and flow cytometric data. Integrative analysis reveals that a core network of transcription factors mediates dynamic shifts in neutrophil-to-lymphocyte ratios (NLR), which are underpinned by cell-type specific methylation patterns in the two cell types. Genetic variants are associated with lower NLRs at birth, and healthy newborns with lower NLRs at birth are more likely to subsequently develop sepsis. These findings provide valuable insights into the early-life determinants of immune system development.

12 May 2021 in Bioinformatics
Verified
Journal Article
Closed access
PDF file
JCJavier J Castillo-Arnemann
Javier J Castillo-Arnemann
OSOlga Solodova
Olga Solodova
BDBhavjinder K Dhillon
Bhavjinder K Dhillon
RHRobert E. W. Hancock
Robert E. W. Hancock
The Pseudomonas aeruginosa Interaction Database, PaIntDB, is an intuitive web-based tool for network-based systems biology analyses using protein–protein interactions (PPI) in this medically important pathogen. It enables the integration and visualization of omics analyses including RNA-Seq and Tn-Seq. High-throughput datasets can be mapped onto PPI networks, which can be explored visually and filtered to uncover novel putative molecular pathways related to the conditions of study. PaIntDB contains the most comprehensive P.aeruginosa interactome to date, collected from a variety of resources, including interactions predicted computationally to further expand analysis capabilities. The web server implementation makes it easily extendable to other bacterial species. PaIntDB is freely available at https://www.paintdb.ca, the source code and database file are available at https://github.com/yavyx/PaIntDB. Supplementary data are available at Bioinformatics online.

1 June 2026 in Nature Communications
Verified
Journal Article
Open access
BDBhavjinder K. Dhillon
Bhavjinder K. Dhillon
TBTravis Blimkie
Travis Blimkie
OIOlubukola T. Idoko
Olubukola T. Idoko
RFRebecca Ford
Rebecca Ford
AAAsimenia Angelidou
Asimenia Angelidou
RHRobert E. W. Hancock
Robert E. W. Hancock
Previous research has shown that immune development during the first week of life, i.e. ontogeny, is progressive, consistent and robust, involving large numbers of differentially expressed genes at each sampled time point. To obtain more granular detail about conserved and population-specific ontogeny, the influence of day of life on blood gene expression and cell type composition was examined in two distinct neonatal populations, from The Gambia and Papua New Guinea, employing block randomization strategies to minimize batch effects. This enabled more detailed conclusions about ontogenic program differences between the two cohorts. Population-specific ontogeny revealed mechanistic insights likely to contribute to inherent population-based heterogeneity in the efficiency of neonatal immune responses, including cell cycle, kinesins, and DAP12 signaling in Papua New Guinea, and antigen presentation, clathrin-mediated endocytosis and alpha-defensins in The Gambia. Differences between populations interconnect using protein:protein interaction networks of population-specific genes and pathinkR-based pathway networks and heat maps, thus fitting the concept of pathway/network remodeling. In addition to the population-specific changes, there is a profound core ontogenic gene-expression program involving ~18% of all expressed genes with remarkable 88-96% conservation at each day of life, revealing new contributors to this shared early-life ontogenic program.

13 January 2026 in Blood Red Cells & Iron
Verified
Journal Article
Open access
ACAbhinav K. Checkervarty
Abhinav K. Checkervarty
CSCasey P. Shannon
Casey P. Shannon
TBTravis Blimkie
Travis Blimkie
BDBhavjinder K. Dhillon
Bhavjinder K. Dhillon
RFReza Falsafi
Reza Falsafi
STScott J. Tebbutt
Scott J. Tebbutt
Sickle cell trait (SCT) is a genetic condition characterized by a heterozygous A-T substitution (Glu to Val) in 1 copy of the β-globin (HBB) gene on chromosome 11. Although often asymptomatic, individuals with SCT can experience complications under stress, such as hypoxia, dehydration, and extreme exertion, leading to vaso-occlusion, organ damage, and impaired immune defenses. Understanding the impact of SCT on the immune system may aid in preventing clinical complications. We genotyped 720 newborns from The Gambia, West Africa, an area in which people are prone to have sickle cell disorders, using RNA-sequencing reads mapped to the HBB gene to identify those with SCT and investigate immune development using single-omics and multiomics approaches. We identified 118 newborns (~17%) with SCT and 4 (0.6%) with sickle cell disease (SCD). Newborns with SCT demonstrated distinct molecular signatures across day of life (DOL) 0, 1, 3, and 7, compared with those without, including reduction of DOL 3 plasma proteins (eg, cysteine-rich secretory protein-3, inter-α-trypsin inhibitor 1, tetranectin, and cadherin-5). Additionally, we observed enrichment of pathways previously associated with SCD, such as the Jison sickle cell pathway, along with those linked to hematologic (chronic leukemia), hepatic (liver cancer), and renal (aging kidney) functions and disorders. These SCT-based associations were validated in an independent cohort of 45 neonates. Despite the absence of overt early clinical phenotypes, SCT-associated changes manifest in the first week of life at the molecular level. Monitoring and characterizing these associations may enable the identification of future disease risks and the development of preventive strategies. This trial was registered at www.clinicaltrials.gov as #NCT03246230.